US FDA Approves Darzalex Faspro (daratumumab and hyaluronidase-fihj) for High-Risk Smoldering Multiple Myeloma (https://www.myeloma.org/news-events/multiple-myeloma-news/fda-approves-darzalex-faspro-daratumumab-hyaluronidase-fih-hr-smm)

Source URL: https://www.myeloma.org/news-events/multiple-myeloma-news/fda-approves-darzalex-faspro-daratumumab-hyaluronidase-fih-hr-smm